baber/WOPTO huggingface dataset:
Patent EP-2277469-A2 (EP)
Inventor: GRUENIG DANIEL
IPC: A61B17/16
Filed: 2005-05-17
Abstract: The tool has an oscillatory drive (3), where force of the oscillator drive is transmitted to a tool holder (25) by a drive unit (17). A longitudinal opening extends through the tool to allow a guide wire for guiding the implant, to be guided through the tool. The tool holder comprises a seat that retains the tool in different orientations, where the holder is made of a combination of light metal and steel. A saddle shaped coupling (24) is provided between the tool holder and the drive unit. An independent claim is also included for a tool holder for a percussion tool.
Patent EP-2206888-A2 (EP)
Inventor: FLANAGAN MARK W
IPC: F01D11/18
Filed: 2010-01-05
Abstract: A turbine power generation system, comprising a stator (18) including a shroud and a rotor (28) rotatably situated within the shroud, wherein the shroud is structured such that the inner diameter of the inner surface (26) of the shroud reduces when the inner surface (26) is exposed to a thermal load. The reduction of the inner diameter allows a minimum blade-casing clearance to be achieved during steady-state operation instead of during transient operations. Blade-casing clearance is configured to be greatest at when the engine is in a cold, stationary position. The clearance is further configured to decrease as thermal load increases until a steady-state, thermal equilibrium is achieved. The clearance grows during shutdown as the stator and rotor begin to cool.
Patent EP-2257097-A2 (EP)
Inventor: REUDINK DOUGLAS
IPC: H04W88/08
Filed: 2010-02-25
Abstract: Base stations and mobile devices have limited radio frequency spectrum through which they may communicate. Moreover, this spectrum is usually owned by a party having proprietary control. In order to allow for spectrum sharing, cognitive base stations (CBS) may be configured to select a radio frequency channel owned by another entity for its own use, and to determine how much additional noise it will create for such other entity. Based on this determination, the additional noise may be monetized, so that spectrum owners may be compensated for the additional noise created by use of their radio frequency channel.
Patent EP-2249165-A2 (EP)
Inventor: HAMADA YUICHI
IPC: G01N35/00
Filed: 2010-05-04
Abstract: A specimen processing device comprising: first and second units for processing specimens; a conveyance unit for conveying a specimen rack in a first direction from a first position where the specimen is retrieved by the first unit to a second position where the specimen is retrieved by the second unit, and a second direction opposite to the first position; a detector common to the first and second units for executing a detection process with respect to the sample containers; and a conveyance controller controlling the conveyance unit to convey some sample containers of the detected sample containers executed with the detection process to the first position, and to convey the other sample containers of the detected sample containers to the second position, the some sample containers and the other sample containers being held by a common rack, is disclosed.
Patent EP-2226957-A2 (EP)
Inventor: KO WOO SUK
IPC: H04L5/00
Filed: 2008-12-19
Abstract: There is disclosed a method of transmitting a broadcasting signal, the method comprising encoding layer-1, L1, signaling data; bit-interleaving bits of the encoded L1 signaling data; encoding Physical Layer Pipe, PLP, data delivering service data; building a signal frame including the encoded PLP data and a preamble including the bit-interleaved L1 signaling data; and transmitting the signal frame. 
     An inter-related method of receiving a broadcast signal, as well as inter-related apparatuses are also described.
Patent EP-2366774-A2 (EP)
Inventor: METZ JAMES G
IPC: A61P15/06
Filed: 2002-04-16
Abstract: The invention generally relates to polyunsaturated fatty acid (PUFA) polyketide synthase (PKA) systems isolated from or derived from non-bacterial organisms, to homologues thereof, to isolated nucleic acid molecules and recombinant nucleic acid molecules encoding biologically active domains of such a PUFA PKS system, to methods of making and using such system for the production of bioactive molecules of interest, and to novel methods for identifying new bacterial and non-bacterial microorganisms having such a PUFA PKS system.
Patent EP-2289513-A2 (EP)
Inventor: DEMUTH HANS-ULRICH
IPC: A61K38/55
Filed: 1997-04-24
Abstract: Use of "effectors" of dipeptidyl peptidase IV (DP IV) activity for lowering the blood sugar level below the glucose concentration characteristic of hyperglycaemia in the serum of a mammal is new.
Patent EP-2233160-A2 (EP)
Inventor: BENNETT STEVEN L
IPC: A61L27/52
Filed: 2010-03-26
Abstract: Some aspects of the present disclosure relate to methods for treating a tissue by forming a low-swelling biodegradable hydrogel in situ adherent to the tissue. In embodiments the hydrogel exhibits negative swelling, i.e., shrinking. Such treatments may be utilized to in cosmetic or reconstructive surgery, in sphincter augmentation, treating nerve inflammation, and the like.
Patent EP-2267103-A2 (EP)
Inventor: ARADI ALLEN A
IPC: C10L1/232
Filed: 2010-06-18
Abstract: The present disclosure relates to a gasoline combustion improver comprising an organic nitro compound with C-NO 2  bond dissociation energy of about 60 to about 80 Kcal/mol of compound, wherein the organic nitro compound is selected from the group consisting of nitro-aromatics, heteroatom aromatic ring compounds, heteroatom nonaromatic ring compounds, and nitrated furfuryls, and wherein the organic nitro compound is not nitrotoluene or dinitrotoluene.
Patent EP-2281765-A2 (EP)
Inventor: SCHNEIDER MARCEL
IPC: B65H29/66
Filed: 2010-07-29
Abstract: The method involves releasing products (10) and moving the products without active conveyance up to impingement on an outgoing conveying surface (322) of a removal conveyor (320). A foremost product is influenced by a movable acceleration element (316) during or immediately and after release of the products, so that the foremost product is given an impulse in a vertical direction and separated from a following product. Formation of an outgoing copy stream comprised of products lying on top of one another on the outgoing conveying surface is performed. An independent claim is also included for a device for inverting copy stream of folded products, comprising guide and conveyor elements.
Patent EP-2415142-A2 (EP)
Title: Moteur synchrone et a induction
Inventor: KALLUF FLAVIO J H
IPC: H02K1/22
Filed: 2010-03-25
Abstract: L'invention concerne un moteur électrique pouvant fonctionner à la fois comme moteur synchrone et comme moteur à induction et comprenant un stator (100) muni d'enroulements de bobine, ainsi qu'un rotor (200) qui est un rotor muni d'aimants (300, 310, 320, 330) générant 4 pôles, les enroulements du stator (100) pouvant être commutés de manière à modifier le nombre de pôles. Le moteur selon l'invention fonctionne comme moteur synchrone à faible rotation et comme moteur à induction en cas de rotation élevée. Lors du fonctionnement en tant que moteur à induction, les rotors (200) sont utilisés avec un rapport de saillance proche de 1, générant ainsi un flux suffisant pour atteindre de bon niveaux d'efficacité avec deux pôles, ce qui empêche le moteur de présenter des oscillations du couple pendant son fonctionnement. L'invention fournit ainsi un moteur à fonctionnement allégé, aux performances améliorées et qui génère moins de bruit.
Patent EP-2427629-A2 (EP)
Inventor: CHURCHILL ANDREW PHILIP
IPC: E21B21/10
Filed: 2010-05-07
Abstract: An activating device (50) is provided for location in downhole tubing. The device defines an activation profile (60) which is initially maintained at a larger diameter than a tubing seat (36), such that the device may land on and be held up by the seat The profile may be subsequently re-configured to radially retract, allowing the device to pass through the seat.
Patent EP-2440512-A2 (EP)
Title: Method for the restabilization of (meth)acrylic monomers
Inventor: HERFERT NORBERT
IPC: C07C51/47
Filed: 2010-05-31
Abstract: The invention relates to a method for the restabilization of (meth)acrylic monomers, whereby phenothiazine is removed from phenothiazine-containing (meth)acrylic monomers by adsorption on activated carbon and optionally subsequent addition of a moderately effective polymerization inhibitor.
Patent EP-2442854-A2 (EP)
Inventor: BOETTGER FRANK
IPC: A61M5/315
Filed: 2010-06-09
Abstract: The invention relates to a piston (5) for a medical hollow body (1), particularly a syringe or a carpule, comprising at least one sliding surface (19) for contact with the hollow body (1). The piston (5) is characterized by at least one receiving area (21), in which a lubricant can be received, and by at least one dispensing means for dispensing the at least one lubricant from the at least one receiving area (21) to the at least one sliding surface (19).
Patent EP-2391688-A2 (EP)
Title: Ruban comprenant du papier recyclé
Inventor: VAN DOORSELAER ROBERT L
IPC: C09J7/21
Filed: 2010-01-28
Abstract: La présente invention porte sur un ruban-cache ayant un support en papier crêpé comprenant du papier recyclé provenant des déchets de consommation (PCW). Le support de papier comprend au moins environ 30 % en poids de papier PCW et conserve une résistance souhaitée à la formation de bûchettes des rubans-caches contenant du papier qui ne provient pas de déchets de consommation (non-PCW) grâce à la sélection d'une vitesse accrue de charge d'un agent d'imprégnation sec d'au moins 40 % en poids. Ceci permet d'obtenir des valeurs de résistance au déchirement en coupe transversale (CD) d'au moins 40 grammes-force (gf).
Patent EP-2473582-A2 (EP)
Title: Conversion pyrolytique de cellulose et/ou hémicellulose dissoute dans un liquide ionique
Inventor: HEINERMAN JACOBUS JOHANNES
IPC: C08B1/00
Filed: 2010-09-01
Abstract: L'invention porte sur un procédé pour convertir de la cellulose en des combustibles liquides. Dans le procédé, la cellulose est dissoute dans un milieu liquide ionique. Le procédé de conversion peut comprendre une pyrolyse, un craquage thermique, un hydrocraquage, un craquage catalytique, un hydrotraitement ou une combinaison de ceux-ci. La cellulose dissoute est, de préférence, hydrolysée avant la réaction de conversion. Le milieu liquide ionique est, de préférence, un hydrate d'un sel fondu inorganique.
Patent EP-2433065-A2 (EP)
Title: Réfrigérateur comprenant un dispositif de fabrication de glaçons et procédé de commande associé
Inventor: LEE TAE HEE
IPC: F25C1/00
Filed: 2010-04-15
Abstract: L'invention concerne un réfrigérateur et un procédé de commande associé, dans lequel la vitesse de fabrication de glaçons est régulée. Un mode de fonctionnement de fabrication de glaçons peut être déterminé, et, en fonction de la détermination du mode de fonctionnement de fabrication de glaçons, une température interne du compartiment de fabrication de glaçons peut être régulée à une température appropriée. Par exemple, une vitesse de fonctionnement d'un ventilateur d'air froid et/ou une vitesse de rotation du ventilateur d'air froid peuvent être contrôlées.
Patent EP-2455079-A2 (EP)
Inventor: KWON BYOUNG-MOG
IPC: A61P19/10
Filed: 2010-07-16
Abstract: The present invention relates to a pharmaceutical composition for the prevention or treatment of bone diseases comprising colforsin daropate, and more particularly, the present invention relates to a pharmaceutical composition for the prevention or treatment of bone diseases such as bone fracture and osteoporosis, which inhibits osteoclast differentiation and bone resorption caused by osteoclasts and promotes osteoblast differentiation and the activity of osteoblasts, and a health functional food composition comprising colforsin daropate.
Patent EP-2475515-A2 (EP)
Title: Films optiques à morphologie de surface contrôlée et leur procédé de fabrication
Inventor: CHO YONG GYUN
IPC: B29D11/00
Filed: 2010-09-02
Abstract: L'invention concerne un film optique que l'on utilise dans des dispositifs d'affichage à panneau plat (FPD), ainsi qu'un procédé de fabrication de ce dernier. L'invention concerne plus particulièrement un procédé permettant de conférer une rugosité de surface à un film optique, lequel consiste à former des cratères renfoncés ayant un rayon de courbure de 10 nm à 100 μm sur la surface d'un film optique obtenu par un processus de coulage de solution, et à former un plateau central entre deux cratères. L'invention concerne également un film optique obtenu selon ce procédé.
Patent EP-2502237-A2 (EP)
Title: Alimentation haute tension pour un générateur compact de rayonnement
Inventor: PERKINS LUKE T
IPC: H05H1/02
Filed: 2010-11-15
Abstract: La présente invention concerne un outil de diagraphie nucléaire comprenant un logement d'outil ; un générateur compact qui produit un rayonnement ; une alimentation en énergie couplée au générateur compact ; et des circuits de commande. Des modes de réalisation du générateur compact comprennent un tube à vide de générateur comprenant une source produisant des particules chargées et une cible vers laquelle sont dirigées les particules chargées ; et une alimentation haute tension comprenant une échelle multiplicatrice haute tension située de façon latéralement adjacente au tube à vide du générateur. L'alimentation haute tension applique une haute tension entre la source et la cible pour accélérer les particules chargées à un niveau énergétique prédéfini. Le générateur compact comprend également un couplage électrique entre une sortie de l'alimentation haute tension et la cible du tube à vide du générateur afin d'accueillir les positions co-implantées du tube à vide du générateur et l'alimentation haute tension.
Patent EP-2400010-A2 (EP)
Inventor: SAHIN UGUR
IPC: A61K39/00
Filed: 2003-11-21
Abstract: Pharmaceutical composition (A) comprises an agent (I) that inhibits the expression or activity of a tumor-associated antigen (TAg) that is encoded by a nucleic acid (NA) that: (a) is any of 22 specified sequences (reproduced) or their fragments or derivatives; (b) hybridizes to (a) under stringent conditions; (c) is a degenerate variant of (a) or (b); or (d) is the complement of (a)-(c). Independent claims are also included for: (1) pharmaceutical composition (A1) comprising an agent (Ia) with tumor-inhibiting activity that is selective for cells showing (abnormal) expression of TAg; (2) pharmaceutical composition (A2) comprising an agent (Ib) that selectively increases the amount of complex formed between an HLA molecule and TAg, or its fragments; (3) pharmaceutical composition (A3) containing one or more of TAg (or its fragments), NA that encodes TAg, antibodies (Ab) that bind TAg, antisense nucleic acids that hybridize specifically to NA, and host cells that express TAg; (4) diagnosing a disease associated with (abnormal) expression of TAg; (5) determining regression, progression or onset of a disease associated with (abnormal) expression of TAg; (6) treating a disease associated with (abnormal) expression of TAg; (7) treatment, diagnosis or monitoring of a disease associated with (abnormal) e xpression of TAg; (8) inhibiting development of cancer by administering any of A1-A3; (9) new nucleic acid (NA1) that is any of 3 specified sequences (reproduced; included within NA), their fragments or derivatives, degenerate variants, complements or sequences that hybridize to them; (10) nucleic acid (NA2) that encodes a protein/polypeptide having any of 4 amino acid (aa) sequences reproduced, or their fragments or derivatives; (11) recombinant DNA or RNA (NA3) that comprises NA1 or NA2; (12) host cells that contain NA1-NA3; (13) protein or polypeptide (P) encoded by NA1 or containing the aa sequences of (10); (14) immunogenic fragments of (P) and fragments that can bind to human HLA receptor or to human antibodies; (15) agent (X) that binds specifically to a protein/polypeptide, or its fragments, that is encoded by NA; (16) antibodies (Ab) that bind specifically to a complex formed from a polypeptide/protein encoded by NA and an HLA molecule, but nor to either component alone; (17) conjugate of (X) or Ab wi th a therapeutic or diagnostic agent (Y); (18) kit for detecting (abnormal) expression of TAg; and (19) recombinant DNA molecule that includes a promoter region derived from any of the 22 sequences specified for NA. ACTIVITY : Cytostatic. No details of tests for cytostatic activity are given. MECHANISM OF ACTION : Induction of an immune response or of cytokine secretion, or antisense inhibition of gene expression.
Patent EP-2372516-A2 (EP)
Inventor: HENDERSON ANDREW
IPC: G06F3/048
Filed: 2011-03-01
Abstract: Systems and methods of arranging a plurality of icons on a touch sensitive display device of a computing device include receiving contact information from the touch sensitive display device indicating a first and a second one of the plurality of icons have been moved until they touch each other on the touch sensitive display device. A new folder is automatically created responsive to the received contact information indicating the first and second icons have been moved until they touch. The new folder includes stored resources of the computing device associated with the first and the second icons. The first and second icons are replaced on the touch sensitive display device with a new icon associated with the new folder.
Patent EP-2330493-A2 (EP)
Inventor: HOTELLING STEVEN PORTER
IPC: G06F3/041
Filed: 2007-06-08
Abstract: Disclosed herein are liquid-crystal display (LCD) touch screens that integrate the touch sensing elements with the display circuitry. The integration may take a variety of forms. Touch sensing elements can be completely implemented within the LCD stackup but outside the not between the color filter plate and the array plate. Alternatively, some touch sensing elements can be between the color filter and array plates with other touch sensing elements not between the plates. In another alternative, all touch sensing elements can be between the color filter and array plates. The latter alternative can include both conventional and in-plane-switching (IPS) LCDs. In some forms, one or more display structures can also have a touch sensing function. Techniques for manufacturing and operating such displays, as well as various devices embodying such display are also disclosed.
Patent EP-2384972-A2 (EP)
Inventor: BARBOSA WEBER BRITO
IPC: B64D37/20
Filed: 2011-05-05
Abstract: Methods and systems are provided to comply with structural load requirements applicable to aircraft additional fuel tank systems. A plurality of aircraft fuel tanks (100,200) may be positioned adjacent to one another, preferably within the fuselage (10-1) (e.g., a cargo compartment) of the aircraft so as to be disposed generally along a longitudinal axis of the aircraft. The tank body defining an interior space for holding aircraft fuel, an intercommunication conduit assembly (104,105) between the fuel tank modules configured to refuel and transfer fuel from the tank modules by a cascade mode and an intentional air-filled ullage space are operatively associated with the tank body to prevent an overpressure condition within the interior space of the fuel tank body. The intentional air-filled ullage is obtained through the predetermined positioning of the terminal open end of the intercommunication tube inside the respective fuel tank module. The intentional air-filled ullage can be configured in all or in only some of the fuel tank modules according to the design of the auxiliary fuel tanks or aircraft structural loads requirements.
Patent EP-2407906-A2 (EP)
Inventor: ZIMMER VINCENT J
IPC: G06F9/445
Filed: 2011-06-08
Abstract: In one embodiment, a semiconductor integrated code (SIC) may be provided in a binary format by a processor manufacturer. This SIC may include platform independent code of the processor manufacturer. Such code may include embedded processor logic to initialize the processor and at least one link that couples the processor to a memory, and embedded memory logic to initialize the memory. Other embodiments are described and claimed.
Patent EP-2444297-A2 (EP)
Inventor: SETSUDA SATOSHI
IPC: B62D5/04
Filed: 2011-10-19
Abstract: A gap adjustment mechanism (90) that moves an upper housing (64) in a direction close to a worm (70) is disposed in a fitting portion (80) between the upper housing (64) and a lower housing (65). The gap adjustment mechanism (90) is disposed in the fitting portion (80) on the side of the worm (70) or in the fitting portion (80) on the other side of the worm (70).
Patent EP-2456065-A2 (EP)
Inventor: EL-REFAIE AYMAN MOHAMED FAWZI
IPC: H02P25/02
Filed: 2011-11-15
Abstract: An electric drive system includes a permanent magnet machine (70) having a rotor (116) and a stator (118) and a power converter (62) electrically coupled to the permanent magnet machine (70) and configured to convert a DC link voltage to an AC output voltage to drive the permanent magnet machine (70). The power converter (62) includes a plurality of silicon carbide switching devices (74-84) having a voltage rating that exceeds a peak line-to-line back electromotive force of the permanent magnet machine (70) at a maximum speed of the permanent magnet machine (70).
Patent EP-2540142-A2 (EP)
Inventor: MIYAZAKI KAZUYA
IPC: G21K1/02
Filed: 2011-02-21
Abstract: La présente invention a pour objet un appareil de production de rayons radioactifs comprenant un second élément de protection, une cible, et un premier élément de protection, qui sont disposés séquentiellement à partir d'un côté de la source d'émission d'électrons. Une distance la plus courte allant d'une partie à intensité maximale de rayonnement de la cible au premier élément de protection est plus courte qu'une distance la plus courte allant de la partie à intensité maximale de rayonnement de la cible au second élément de protection.
Patent EP-2542225-A2 (EP)
Inventor: VISCOMI GIUSEPPE CLAUDIO
IPC: A61K31/437
Filed: 2011-03-04
Abstract: The present invention describes rifaximin powder and to a process for preparing the same. The invention relates also to a pharmaceutical composition in solid form comprising said rifaximin, pharmaceutically acceptable excipients and optionally other ingredients. The compositions according to the invention are suitable for oral administration and are characterized by producing a controlled release of rifaximin, whereby a long-lasting effect is obtained in a patient.
Patent EP-2552284-A2 (EP)
Title: Perfectionnements apportés à des présentoirs réfrigérés
Inventor: WOOD IAN
IPC: A47F3/04
Filed: 2011-03-29
Abstract: L'invention concerne un présentoir réfrigéré (1) comportant une armoire ouverte sur le devant qui offre un espace de présentation de produits (3) accessible par une ouverture d'accès (39) constituée par l'ouverture sur le devant. Un moyen de refroidissement (27) produit de l'air froid pour réfrigérer des articles dans l'espace de présentation de produits (3). Un rideau d'air froid est formé au niveau de l'ouverture d'accès (39) au moyen d'une sortie d'émission d'air (5) située à l'avant et en communication avec un conduit d'alimentation (45) et d'une entrée de retour d'air (7) située à l'avant et en communication avec un conduit de retour (41) recevant de l'air du rideau d'air (9). Le rideau d'air (9) ne reçoit sensiblement aucun air d'un quelconque flux d'air de refroidissement supplémentaire introduit dans l'espace de présentation de produits (3) séparément du rideau d'air (9).
Patent EP-2561041-A2 (EP)
Inventor: BORTOLO ROSSELLA
IPC: C10G1/00
Filed: 2011-04-18
Abstract: La présente invention a pour objet un procédé permettant de réduire la viscosité de pétroles bruts lourds in situ, directement au niveau de la tête de puits ou du centre pétrolifère, par « viscoréduction douce », caractérisé en ce que l'énergie nécessaire pour ladite viscoréduction est obtenue au moyen d'une installation de concentration solaire, avant d'être soumis à ladite viscoréduction, lesdits pétroles bruts lourds étant préchauffés par au moins un échange thermique avec les pétroles bruts obtenus ayant une viscosité réduite.